신경가소성 시장 규모는 향후 몇 년 동안 연평균 성장률(CAGR) 23.2%로 2029년까지 151억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 신경 기술 분야에서 인공지능의 통합 증가, 개인화된 신경 치료에 대한 수요 증가, 신경 재활 치료에서 가상현실의 활용 확대, 웨어러블 뇌 모니터링 기기의 채택 확대, 인지 기능 향상에 초점을 맞춘 스타트업에 대한 투자 증가 등에 기인합니다. 인지기능 강화에 초점을 맞춘 스타트업에 대한 투자 증가 등에 기인하는 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 뇌-컴퓨터 인터페이스 기술의 발전, 인지 훈련을 위한 뉴로피드백 기술의 발전, 가정용 신경치료 기기의 개발, 비침습적 뇌자극법의 혁신, 개인화된 뇌 모델링을 위한 디지털 트윈의 등장 등이 있습니다.
신경질환의 부담 증가는 고급 뇌 치료에 대한 수요 증가로 인해 신경가소성 시장의 성장을 견인하고 있습니다. 신경 질환의 발생이 증가하고 있는 것은 향후 시장 성장을 촉진할 것으로 예측됩니다. 뇌, 척수, 신경계에 영향을 미치는 이러한 질환은 다양한 신체적, 인지적, 행동적 장애를 초래합니다. 알츠하이머병, 파킨슨병, 간질, 다발성 경화증과 같은 질병은 인구의 고령화 및 생활습관 관련 요인이 주요 원인으로 작용하여 더욱 확산되고 있습니다. 전 세계적으로 평균 수명이 늘어남에 따라 노화에 따른 신경질환의 발병 위험은 증가하고 있으며, 이는 전 세계적으로 발병률 증가에 기여하고 있습니다. 이러한 질병의 확산은 뇌 기능과 환자의 예후를 개선할 수 있는 혁신적인 치료법과 재활 기술에 대한 수요를 증가시키고 있습니다. 이러한 추세는 신경가소성 기반 치료의 발전을 뒷받침하고 있습니다. 예를 들어, 2023년 10월 영국에 본부를 둔 세계 신경학회의 연합체인 세계신경학연맹(World Federation of Neurology)은 현재 전 세계 인구의 40% 이상이 신경질환을 앓고 있으며, 이 수치는 2050년까지 거의 두 배로 늘어날 것으로 예측된다고 보고했습니다. 결과적으로 신경질환의 유병률 증가는 신경가소성 시장의 성장에 크게 기여하고 있습니다.
신흥국의 신경가소성 시장은 경쟁력을 유지하기 위해 뇌-컴퓨터 인터페이스(BCI) 및 신경 임플란트와 같은 첨단 기술 개발에 점점 더 집중하고 있습니다. 이러한 첨단 신경기술은 뇌와 외부 시스템 사이에 직접적인 통신 채널을 생성하며, BCI는 일반적으로 뇌의 신호를 사용하여 컴퓨터나 인공장치를 조작할 수 있도록 하며, 신경 임플란트는 뇌와 신경계에 삽입되어 치료 및 기능 개선을 위해 신경 활동을 모니터링, 자극, 자극, 영향을 주는 것입니다. 자극, 영향을 주는 것입니다. 예를 들어, 2024년 6월, 미국에 본사를 둔 뉴로테크놀러지 기업 파라드로믹스(Paradromics)는 FDA의 규제 가속화 프로그램에 채택되어 새로운 환자 등록을 시작했습니다. 이 이정표는 파라드로믹스의 고성능 뇌-컴퓨터 인터페이스 개발의 중요한 단계이며, 첨단 신경 데이터 솔루션을 통해 중증 신경장애 환자들의 치료 옵션에 혁명을 일으킬 수 있는 신경기술의 큰 혁신을 반영합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 신경가소성 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 신경가소성 시장 : 성장률 분석
- 세계의 신경가소성 시장 규모·성장률 : 실적치, 2019-2024년
- 세계의 신경가소성 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
- 세계의 신경가소성 시장 : 총유효과 시장(TAM)
제6장 시장 세분화
- 세계의 신경가소성 시장 : 제품 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 소프트웨어 기반 솔루션
- 하드웨어 기반 솔루션
- 세계의 신경가소성 시장 : 기술 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 인공지능
- 가상현실
- 신경자극
- 웨어러블 테크놀러지
- 세계의 신경가소성 시장 : 용도별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 뇌졸중 재활
- 외상성 뇌손상(TBI) 재활
- 신경변성질환
- 학습·기억 강화
- 정신질환
- 세계의 신경가소성 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원·진료소
- 연구기관·학술 센터
- 제약·바이오테크놀러지 기업
- 기타 최종사용자
- 세계의 신경가소성 시장 : 소프트웨어 기반·솔루션 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 인지 트레이닝 프로그램
- 뉴로피드백 소프트웨어
- 뇌시뮬레이션 플랫폼
- 모바일 신경 요법 앱
- VR 재활 소프트웨어
- AI 기반 인지 평가 툴
- 세계의 신경가소성 시장 : 하드웨어 기반·솔루션 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- EEG 헤드셋
- 경두개 자기 자극(TMS) 장비
- 경두개 직류 전류 자극(tDCS) 장비
- 뇌컴퓨터 인터페이스(BCI) 시스템
- 웨어러블 신경자극 기기
- 신경 영상·모니터링 기기
제7장 지역별·국가별 분석
- 세계의 신경가소성 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 세계의 신경가소성 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 신경가소성 시장 : 경쟁 구도
- 신경가소성 시장 : 기업 개요
- Abbott Laboratories(개요, 제품 및 서비스, 전략, 재무 분석)
- Medtronic PLC(개요, 제품 및 서비스, 전략, 재무 분석)
- Otsuka Pharmaceutical(개요, 제품 및 서비스, 전략, 재무 분석)
- Boston Scientific Corporation(개요, 제품 및 서비스, 전략, 재무 분석)
- Biogen Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
- Neurocrine Biosciences
- Axsome Therapeutics
- NeuroPace Inc.
- BrainsWay Ltd.
- Magstim
- MindMaze
- Emotiv Inc.
- BrainCo
- ElectroCore
- NeuroMetrix
- Sage Therapeutics
- Soterix Medical
- Neurable
- NeuroSigma Inc.
- Cognixion
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
- 신경가소성 시장 : 최신 기회를 제공하는 국가(2029년)
- 신경가소성 시장 : 최신 기회를 제공하는 부문(2029년)
- 신경가소성 시장 : 성장 전략(2029년)
제36장 부록
ksm
Neuroplasticity refers to the brain's capacity to reorganize and adjust by creating new neural connections throughout an individual's lifetime. This ability allows the brain to respond to new experiences, learning processes, and injuries by either strengthening or weakening synapses. The primary objective of neuroplasticity is to facilitate cognitive flexibility, learning, memory retention, and recovery following brain injury. Additionally, it contributes to skill enhancement, boosts mental resilience, aids in rehabilitation, and supports the brain's long-term health and adaptability.
The primary categories of neuroplasticity products consist of software-based and hardware-based solutions. Software-based approaches involve digital tools and programs aimed at enhancing brain performance by activating neural circuits. These include cognitive training applications, virtual reality environments, and brainwave modulation software designed to support learning, memory, and post-injury recovery. Technologies used in this area include artificial intelligence, virtual reality, neurostimulation, and wearable devices. These solutions are applied in areas such as stroke recovery, traumatic brain injury (TBI) treatment, neurodegenerative disease management, cognitive enhancement, and mental health care. They are utilized by hospitals and clinics, academic and research institutions, pharmaceutical and biotech firms, among others.
The neuroplasticity market research report is one of a series of new reports from The Business Research Company that provides neuroplasticity market statistics, including neuroplasticity industry global market size, regional shares, competitors with a neuroplasticity market share, detailed neuroplasticity market segments, market trends and opportunities, and any further data you may need to thrive in the neuroplasticity industry. This neuroplasticity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neuroplasticity market size has grown exponentially in recent years. It will grow from $5.34 billion in 2024 to $6.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.4%. Growth during the historic period can be credited to the growing interest in brain-computer interface technologies, expanded funding for neuroscience research, the global rise in mental health issues, increasing clinical validation of therapies based on neuroplasticity, and the heightened adoption of digital therapeutics in cognitive healthcare.
The neuroplasticity market size is expected to see exponential growth in the next few years. It will grow to $15.18 billion in 2029 at a compound annual growth rate (CAGR) of 23.2%. Growth in the forecast period can be attributed to the increasing integration of artificial intelligence in neurotechnology, rising demand for personalized neurotherapies, expanding use of virtual reality in neurorehabilitation, greater adoption of wearable brain-monitoring devices, and growing investments in startups focused on cognitive enhancement. Major trends expected during this period include advancements in brain-computer interface technologies, progress in neurofeedback techniques for cognitive training, the development of home-based neurotherapy devices, innovations in non-invasive brain stimulation methods, and the emergence of digital twins for personalized brain modeling.
The growing burden of neurological disorders is driving the expansion of the neuroplasticity market due to rising demand for advanced brain therapies. The increasing occurrence of neurological conditions is anticipated to fuel market growth moving forward. These disorders, which affect the brain, spinal cord, and nervous system, result in various physical, cognitive, and behavioral impairments. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis are becoming more widespread, largely due to aging populations and lifestyle-related factors. As global life expectancy increases, the risk of developing age-related neurological disorders rises, contributing to higher incidence rates across the world. The prevalence of these conditions is generating greater demand for innovative therapies and rehabilitation technologies that improve brain function and patient outcomes. This trend supports the advancement of neuroplasticity-based treatments. For example, in October 2023, the World Federation of Neurology, a UK-based organization of national neurological societies, reported that over 40% of the global population is currently affected by some form of neurological condition, and this figure is projected to nearly double by 2050. As a result, the rising prevalence of neurological disorders is significantly contributing to the growth of the neuroplasticity market.
Key players in the neuroplasticity market are increasingly focused on developing sophisticated technologies such as brain-computer interfaces (BCIs) and neural implants to maintain their competitive edge. These advanced neurotechnologies create direct communication channels between the brain and external systems. BCIs typically allow users to control computers or prosthetic devices using brain signals, while neural implants are inserted into the brain or nervous system to monitor, stimulate, or influence neural activity for therapeutic or functional improvement. For example, in June 2024, Paradromics, a U.S.-based neurotechnology firm, was accepted into the FDA Regulatory Accelerator Program and launched a new patient registry. This milestone represents a significant step in the development of the company's high-performance brain-computer interfaces, reflecting major innovation in neurotechnology that holds potential to revolutionize treatment options for individuals with severe neurological disorders through advanced neural data solutions.
In April 2022, Blackrock Neurotech, a brain-computer interface company based in the U.S., acquired MindX for an undisclosed amount. This acquisition reinforces Blackrock's end-to-end BCI platform by enhancing its capabilities in developing commercial-grade brain-computer interface technologies. The integration of MindX's spatial computing software is expected to accelerate the development and commercialization of next-generation neural interface systems designed for medical use. MindX, also based in the U.S., specializes in creating spatial computing software for augmented reality and neural interface applications.
Major players in the neuroplasticity market are Abbott Laboratories, Medtronic PLC, Otsuka Pharmaceutical, Boston Scientific Corporation, Biogen Inc., Neurocrine Biosciences, Axsome Therapeutics, NeuroPace Inc., BrainsWay Ltd., Magstim, MindMaze, Emotiv Inc., BrainCo, ElectroCore, NeuroMetrix, Sage Therapeutics, Soterix Medical, Neurable, NeuroSigma Inc., Cognixion, and NeuroTracker.
North America was the largest region in the Neuroplasticity market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroplasticity report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the neuroplasticity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neuroplasticity market consists of revenues earned by entities by providing services such as cognitive rehabilitation, brain training solutions, neurostimulation therapies, and neurological recovery programs that enhance or restore the brain's adaptive capacity across various neurological and psychiatric conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroplasticity market also includes sales of electroencephalogram (EEG), transcranial direct current stimulation (tDCS) devices, and meditation biofeedback sensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neuroplasticity Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neuroplasticity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neuroplasticity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroplasticity market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Software-Based Solutions; Hardware-Based Solutions
- 2) By Technology Type: Artificial Intelligence; Virtual Reality; Neurostimulation; Wearable Technology
- 3) By Application: Stroke Rehabilitation; Traumatic Brain Injury (TBI) Rehabilitation; Neurodegenerative Disorders; Learning And Memory Enhancement; Mental Health Disorders
- 4) By End User: Hospitals And Clinics; Research Institutes And Academic Centers; Pharmaceutical And Biotechnology Companies; Other End Users
- Subsegment:
- 1) By Software-Based Solutions: Cognitive Training Programs, Neurofeedback Software, Brain Simulation Platforms, Mobile Neurotherapy Apps, Virtual Reality Rehabilitation Software, AI-Based Cognitive Assessment Tools
- 2) By Hardware-Based Solutions: EEG Headsets, Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Brain-Computer Interface (BCI) Systems, Wearable Neurostimulation Devices, Neuroimaging And Monitoring Equipment
- Companies Mentioned: Abbott Laboratories; Medtronic PLC; Otsuka Pharmaceutical; Boston Scientific Corporation; Biogen Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neuroplasticity Market Characteristics
3. Neuroplasticity Market Trends And Strategies
4. Neuroplasticity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Neuroplasticity Growth Analysis And Strategic Analysis Framework
- 5.1. Global Neuroplasticity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Neuroplasticity Market Growth Rate Analysis
- 5.4. Global Neuroplasticity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Neuroplasticity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Neuroplasticity Total Addressable Market (TAM)
6. Neuroplasticity Market Segmentation
- 6.1. Global Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software-Based Solutions
- Hardware-Based Solutions
- 6.2. Global Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Artificial Intelligence
- Virtual Reality
- Neurostimulation
- Wearable Technology
- 6.3. Global Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stroke Rehabilitation
- Traumatic Brain Injury (TBI) Rehabilitation
- Neurodegenerative Disorders
- Learning and Memory Enhancement
- Mental Health Disorders
- 6.4. Global Neuroplasticity Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Research Institutes And Academic Centers
- Pharmaceutical And Biotechnology Companies
- Other End Users
- 6.5. Global Neuroplasticity Market, Sub-Segmentation Of Software-Based Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cognitive Training Programs
- Neurofeedback Software
- Brain Simulation Platforms
- Mobile Neurotherapy Apps
- Virtual Reality Rehabilitation Software
- AI-Based Cognitive Assessment Tools
- 6.6. Global Neuroplasticity Market, Sub-Segmentation Of Hardware-Based Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- EEG Headsets
- Transcranial Magnetic Stimulation (TMS) Devices
- Transcranial Direct Current Stimulation (tDCS) Devices
- Brain-Computer Interface (BCI) Systems
- Wearable Neurostimulation Devices
- Neuroimaging And Monitoring Equipment
7. Neuroplasticity Market Regional And Country Analysis
- 7.1. Global Neuroplasticity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Neuroplasticity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neuroplasticity Market
- 8.1. Asia-Pacific Neuroplasticity Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neuroplasticity Market
- 9.1. China Neuroplasticity Market Overview
- 9.2. China Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neuroplasticity Market
- 10.1. India Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neuroplasticity Market
- 11.1. Japan Neuroplasticity Market Overview
- 11.2. Japan Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neuroplasticity Market
- 12.1. Australia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neuroplasticity Market
- 13.1. Indonesia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neuroplasticity Market
- 14.1. South Korea Neuroplasticity Market Overview
- 14.2. South Korea Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neuroplasticity Market
- 15.1. Western Europe Neuroplasticity Market Overview
- 15.2. Western Europe Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neuroplasticity Market
- 16.1. UK Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neuroplasticity Market
- 17.1. Germany Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neuroplasticity Market
- 18.1. France Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neuroplasticity Market
- 19.1. Italy Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neuroplasticity Market
- 20.1. Spain Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neuroplasticity Market
- 21.1. Eastern Europe Neuroplasticity Market Overview
- 21.2. Eastern Europe Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neuroplasticity Market
- 22.1. Russia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neuroplasticity Market
- 23.1. North America Neuroplasticity Market Overview
- 23.2. North America Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neuroplasticity Market
- 24.1. USA Neuroplasticity Market Overview
- 24.2. USA Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neuroplasticity Market
- 25.1. Canada Neuroplasticity Market Overview
- 25.2. Canada Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neuroplasticity Market
- 26.1. South America Neuroplasticity Market Overview
- 26.2. South America Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neuroplasticity Market
- 27.1. Brazil Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neuroplasticity Market
- 28.1. Middle East Neuroplasticity Market Overview
- 28.2. Middle East Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neuroplasticity Market
- 29.1. Africa Neuroplasticity Market Overview
- 29.2. Africa Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neuroplasticity Market Competitive Landscape And Company Profiles
- 30.1. Neuroplasticity Market Competitive Landscape
- 30.2. Neuroplasticity Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Otsuka Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Neuroplasticity Market Other Major And Innovative Companies
- 31.1. Neurocrine Biosciences
- 31.2. Axsome Therapeutics
- 31.3. NeuroPace Inc.
- 31.4. BrainsWay Ltd.
- 31.5. Magstim
- 31.6. MindMaze
- 31.7. Emotiv Inc.
- 31.8. BrainCo
- 31.9. ElectroCore
- 31.10. NeuroMetrix
- 31.11. Sage Therapeutics
- 31.12. Soterix Medical
- 31.13. Neurable
- 31.14. NeuroSigma Inc.
- 31.15. Cognixion
32. Global Neuroplasticity Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neuroplasticity Market
34. Recent Developments In The Neuroplasticity Market
35. Neuroplasticity Market High Potential Countries, Segments and Strategies
- 35.1 Neuroplasticity Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Neuroplasticity Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Neuroplasticity Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
